Corporate events

• May 31 – June 3, 2024

  Alethia Biotherapeutics to present at the Annual ASCO Meeting at McCormick Place · Chicago, IL, USA. Dr. Normand Blais, Dr. Mario Filion, Dr. Jacques Jolivet and Dr. Julie Laurin will present : “A Phase II Trial to Evaluate the Epithelial-to-Mesenchymal (EMT) Inhibitor Sotevtamab Combined with Docetaxel in Patients With Metastatic Non Small Cell Lung Cancer Following Failure of Primary Chemoimmunotherapy”.

  Poster presentation  Abstract 8577, Poster Bd  441, June 3 2024, PM Session.